Osimertinib with Chemotherapy in EGFR-Mutated NSCLC
- PMID: 38294983
- DOI: 10.1056/NEJMc2314600
Osimertinib with Chemotherapy in EGFR-Mutated NSCLC
Comment on
-
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.N Engl J Med. 2023 Nov 23;389(21):1935-1948. doi: 10.1056/NEJMoa2306434. Epub 2023 Nov 8. N Engl J Med. 2023. PMID: 37937763 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous